SUSAN ENGLE: Open Payments
NPI 1467831719 · ALTOOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 13 payments from 8 companies in 2025. Trend: 2023 $525 · 2024 $474 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $46 |
| Novo Nordisk Inc | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: MAVYRET, XIFAXAN, Auvelity, CAPLYTA, MOUNJARO, TRELEGY ELLIPTA, REPATHA, Wegovy.
Industry payments across PA — which companies pay providers there.
